A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label, Long-Term Safety Phase to Evaluate the Efficacy and Safety of TV-44749 in Adults With Schizophrenia
Clinical trial NCT05693935 · COMPLETED
Trial details
- NCT number
- NCT05693935
- Sponsor
- Teva Branded Pharmaceutical Products R&D LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-24
- Primary completion
- 2024-03-19
- Enrollment
- 675
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.